Managing High Cardiac Output Failure in a Patient With Hereditary Hemorrhagic Telangiectasias During Pregnancy

Erica Lynn Smith; Robert Egerman; Arwa Saidi; Ki Park; Ali Ataya

doi:10.1016/j.jaccas.2023.102096

Managing High Cardiac Output Failure in a Patient With Hereditary Hemorrhagic Telangiectasias During Pregnancy

JACC Case Rep. 2023 Dec 6:27:102096. doi: 10.1016/j.jaccas.2023.102096.

Authors

Erica Lynn Smith¹, Robert Egerman¹, Arwa Saidi², Ki Park³, Ali Ataya⁴

Affiliations

¹ Department of Obstetrics and Gynecology, University of Florida, Gainesville, Florida, USA.
² Congenital Heart Center, University of Florida, Gainesville, Florida, USA.
³ Division of Cardiology, University of Florida, Gainesville, Florida, USA.
⁴ Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville, Florida, USA.

Abstract

Hemorrhagic telangiectasias is a rare genetic vascular disorder that may complicate pregnancy. We report a case of a pregnant hemorrhagic telangiectasias patient with innumerable hepatic arteriovenous malformations that developed high output cardiac failure necessitating delivery. Postpartum, the patient was treated with bevacizumab that resulted in clinical improvement.

Keywords: arteriovenous malformation; bevacizumab; hereditary hemorrhagic telangiectasias; high cardiac output failure; liver hemangioma; pregnancy.

Publication types

Case Reports